Bioceltix SA (XI3) Stock Price & News

All values in PLN	Jun. 2025	Sep. 2025	Des. 2025	Mrt. 2026
Revenue	-	-	-	-
Cost of goods sold	501,09 k	536,06 k	533,98 k	1,07 m
Cost of revenue	501,09 k	536,06 k	533,98 k	1,07 m
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	2,85 m	3,67 m	3,86 m	4,62 m
Operating expense	3,20 m	3,91 m	2,88 m	4,70 m
Total operating expenses	3,70 m	4,45 m	3,42 m	5,77 m
Operating income	-3,70 m	-4,45 m	-3,42 m	-5,77 m
Other non operating income	-	-	-	-
EBT including unusual items	-3,73 m	-4,42 m	-3,39 m	-5,68 m
EBT excluding unusual items	-3,73 m	-4,42 m	-3,39 m	-5,68 m
Income tax expense	5,56 k	-40,40 k	516,00	-6,97 k
Effective tax rate	-0,15%	0,91%	-0,02%	0,12%
Other operating expenses	173,25 k	82,21 k	-1,14 m	-80,02 k
Net income	-3,74 m	-4,38 m	-3,39 m	-5,68 m
Net profit margin	-	-	-	-
Earnings per share	-	-	-	-
Interest and investment income	74,80 k	73,53 k	50,46 k	136,82 k
Interest expense	-43,96 k	-34,87 k	-22,48 k	-17,11 k
Net interest expenses	30,83 k	38,67 k	27,98 k	119,71 k
Depreciation and amortization charges	174,36 k	160,78 k	161,63 k	161,65 k
EBITDA	-3,52 m	-4,29 m	-3,25 m	-5,61 m
Gain or loss from assets sale	-	-	-	-

Finance